Dimerix Limited

ASX (AUD): Dimerix Limited (DXB)

Last Price

0.68

Today's Change

+0.20 (41.66%)

Day's Change

0.655 - 0.76

Trading Volume

39,987,280

Profile
DXB

Exchange: 

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO: 

Full Time Employees: 

IPO Date: 

CIK: 

ISIN: 

CUSIP: 

Beta: 

Last Dividend: 

Dcf Diff: 

Dcf: 

Description

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.

Address
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment